Four development candidates in clinical studies with data anticipated this year, continuing rapid progress of antiviral pipeline –– Interim ...

Groundbreaking HIV cure study in South Africa shows the safety and potential efficacy of a novel therapeutic regimen in women ...

"The availability of long-term injectable therapies has not eliminated the phenomenon of multidrug resistance, and heavily ...

The following is a summary of “Telemedicine virologic and immunologic outcomes in people living with HIV (PLWH) in a ...

Theratechnologies (THTX) presented data from a real-world, observational, registry study demonstrating the efficacy and safety of ibalizumab in ...

The trial is designed to assess risk factors and predictors of virologic and immunologic response in HTE people with HIV (PWH) and specific sub-populations. Its primary objective is to evaluate ...

Antiviral therapy with a once-daily single-tablet regimen of doravirine plus islatravir was noninferior to bictegravir plus emtricitabine and tenofovir alafenamide for maintaining HIV virologic ...

“The availability of long-term injectable therapies has not eliminated the phenomenon of multidrug resistance, and heavily treatment-experienced people with HIV deserve fully suppressive ...

“The availability of long-term injectable therapies has not eliminated the phenomenon of multidrug resistance, and heavily treatment-experienced people with HIV deserve fully suppressive ...